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Introduction
Diabetes mellitus is associated with several systemic long-term 
complications including visual impairment, heart and blood vessel 
disease, stroke, kidney failure, amputation, and neuropathy [1]. 
Diabetic retinopathy (DR) remains a leading cause of blindness with 
its incidence increasing as the worldwide number of patients with 
diabetes grows [1]. DR is characterized by microangiopathy of the 
retinal vasculature. Twenty years after diabetes onset, almost 100% of 
patients with type 1 diabetes, and over 60% of type 2 patients, will show 
some degree of retinopathy [2]. Despite improvements in treatments 
such as the intravitreal injection of anti-VEGF (Vascular Endothelial 
Growth Factor) agents, vitreous surgery, and laser photocoagulation, 
progressive vision loss is still unacceptably common [3,4]. 
Characterization of early pathological developments in the diabetic 
retina, even before the onset of vascular pathology, may lead to more 
effective, preventative treatment strategies.
The microvascular theory is the most frequently accepted 
pathophysiological model for DR and its consequent visual loss. The 
focus of the retinal vascular changes is the retinal capillary [5]. The 
neurodegenerative theory has been less extensively investigated [6,7] 
and holds that apoptosis of several neuronal cells including ganglion, 
horizontal, Müller, amacrine and photoreceptor cells, observed early 
in the course of diabetes, is the causative mechanism [8-16]. It has 
been suggested that these neurodegenerative changes might lead to 
microvascular changes [6].
Optical coherence tomography (OCT) is a non-invasive, high-
resolution imaging modality widely used in biomedical optics 
Abstract
Background: To identify local structural and optical derangement in the neural retina of individuals with type 1 
diabetes having early diabetic retinopathy (DR) and compare with healthy non-diabetic controls and type 1 diabetic 
individuals having no DR. 
Methods: Optical coherence tomography (TDOCT) examination was performed on a total of 74 healthy eyes, 38 
eyes with type 1 diabetes mellitus (DM) with no retinopathy and 43 eyes with mild DR (MDR). A total of 6 intraretinal 
layers were segmented on OCT images. Thickness and reflectance-based measurements were extracted for each OCT 
scan using features measured locally for each intraretinal layer. 
Results: In the analysis where local measures were averaged in the separated macular regions outside the foveola, 
the mean thickness values of the outer segment of photoreceptors (OS) in the perifoveal region, ganglion cell and 
inner plexiform layer (GCL+IPL) complex in the parafoveal and outer plexiform layer (OPL) in the foveal region were 
significantly smaller (13%, 8% and 36%; respectively, p<0.001) when comparing MDR eyes with controls. The mean 
thickness values of the OPL (foveal region, 27%, p<0.001) and the OS (parafoveal (24%) and perifoveal (23%), p<0.001) 
were significantly smaller when comparing MDR with DM eyes. The reflectance-based measures were significantly 
smaller for all layers in MDR eyes compared with healthy and DM eyes (7-36%, p<0.001). 
Conclusions: Our results show OCT is capable of detecting selective layer thinning and that the optical properties 
extracted from OCT images add significant evidence to the morphological information directly provided by OCT. It also 
suggests that the outer segment of the photoreceptor layer may be vulnerable in both type 1 diabetic individuals with and 
without early DR. Our results might also indicate that an early sign of vascular alteration development could be detected 
by investigating the changes in optical properties and thickness of the OPL.
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and medicine [17-19]. OCT is particularly suited for ophthalmic 
applications, where its development has been rapid and its clinical 
applicability has revolutionized the diagnosis and monitoring of many 
common posterior segment conditions [19]. The resolution achieved by 
OCT imaging surpasses or complements standard clinical examination 
techniques such as biomicroscopy or angiography. Current studies of 
DR using OCT have mainly focused on later disease stages- proliferative 
and severe non-proliferative DR, and diabetic macular edema [3,15,20]. 
Besides improved resolution capacity, the OCT affords cross-sectional 
detail, which is not otherwise attainable. The capabilities of OCT 
imaging have been employed to study DR at early stages [20-24]. OCT 
quantitatively detects retinal thickening in patients before reaching the 
stage of clinically significant macular edema (CSME). However, these 
studies have been limited to retinal thickness evaluation and have not 
yielded a clinically useful metric [25]. Moreover, in vitro and in vivo 
studies have shown that physiological processes of the retina lead to 
optical density changes that can be observed by a special M-mode 
OCT imaging, known as optophysiology [18,26,27]. Thus, it also seems 
rational that quantitative analysis of reflectance changes may provide 
clinically relevant information about retinal pathophysiology.
Recently, thinning of the macula preceding the onset of severe DR, 
which may be attributed to neurodegeneration of the retinal cellular 
structures, has been reported [28-30]. By extension, thinning at an 
earlier stage might reflect loss of the cellular structures in the inner 
retina, perhaps the ganglion cells [28-30]. Apoptosis of ganglion cells 
might explain the loss of macular function that might be undetectable 
clinically, or unrecognized by standard grading schemes. Such data 
might lead to new perspectives for the follow-up and treatment of DR. 
A better understanding of retinal structural changes in early stages of 
DR may provide information about the mechanism of its progression 
and lead to therapeutic strategies. Such early changes might be 
detectable by measuring thicknesses of individual layers, but OCT can 
also measure other optical properties of tissue by using coherent light.
The purpose of this study is to use time-domain OCT to identify 
local structural and optical derangement in the neural retina of 
individuals with type 1 diabetes having early DR and compare with 
healthy non-diabetic controls and type 1 diabetic individual having no 
DR.
Materials and Methods
The Institutional Review Board in each institution involved in 
the study (University of Miami, Miami, FL, USA and Semmelweis 
University, Budapest, Hungary) approved the study. The research 
adhered to the tenets set forth in the declaration of Helsinki and written 
informed consent was obtained from each subject. In this prospective 
study, enrollment was offered to type 1 diabetic patients referred to 
the comprehensive ophthalmology clinic that had diabetic retinopathy 
up to ETDRS level 35 and without macular edema, as well as type 1 
diabetic patients with no retinopathy [31]. Patients with proliferative 
disease, clinically significant macular edema (CSME), and anatomic 
abnormalities that might confound evaluation of macular architecture, 
such as glaucoma, vitreoretinal traction and epiretinal membranes 
were excluded. Healthy controls were selected if best-corrected visual 
acuity was at least 20/25, a history of any current ocular or systematic 
disease was lacking, and the macula appeared normal when examined 
with contact lens biomicroscopy. Patients with medical conditions that 
might affect visual function, receiving treatments with medications that 
might affect retinal thickness (e.g. chloroquine or niacin containing 
anticholesterol agents), recent cataract surgery, previous vitrectomy, or 
unstable blood sugars were excluded. 
Once enrolled a comprehensive eye examination was performed 
including slit lamp examination, measurement of intraocular pressure 
(using Goldmann tonometer), and fundus biomicroscopy. OCT 
imaging and 2 standard field stereoscopic fundus photos (SFPs) were 
obtained in all patients. The SFPs were classified by independent 
graders according to the criteria of proposed international clinical 
diabetic retinopathy and diabetic macular edema disease severity scales 
based on the ETDRS protocol [32,33]. The graders were unaware of the 
OCT findings and clinical data. In addition, a hemoglobin A1c level 
test was required at this visit for diabetic patients.
The OCT system used in this study (STRATUS OCT, Carl Zeiss 
Meditec, Dublin, California) employs a broadband light source, 
delivering an output power of 1 mW at the central wavelength of 820 
nm with a bandwidth of 25 nm. The light source yields 12 µm axial 
resolution in free space that determines the imaging axial resolution 
of the system. A cross-sectional image is achieved by the combination 
of axial reflectance while the sample is scanned laterally. All STRATUS 
OCT study cases were obtained using the “macular thickness” map 
protocol. This protocol consists of six radial scan lines centered on the 
fovea, each having a 6 mm transverse length. In order to obtain the best 
image quality, focusing and optimization settings were controlled and 
scans were accepted only if the signal strength was above 6 [34]. Scans 
with foveal decentration (i.e. with center point thickness SD>10%) 
were repeated.
Macular radial line scans of the retina for each case were exported 
to disc with the export feature available in the STRATUS OCT device 
and analyzed using a computer-aided grading methodology for OCT 
retinal image analysis (OCTRIMA) developed by Cabrera et al. [35,36]. 
A total of 6 cellular layers of the retina were segmented on OCT images 
based on their optical densities: the retinal nerve fiber layer (RNFL), the 
ganglion cell and inner plexiform layer complex (GCL+IPL), the inner 
nuclear layer (INL), the outer plexiform layer (OPL), the outer nuclear 
layer and inner photoreceptor segment (ONL+IS), outer photoreceptor 
segment (OS) and retinal pigment epithelium (RPE) (Figure 1) [35]. 
As in some Fourier-domain OCT (FD-OCT) systems, OCTRIMA 
facilitates the total retinal thickness calculations between the ILM and 
the inner boundary of the second hyperreflective band, which has been 
attributed to the outer segment/retinal pigment epithelium (OS/RPE) 
junction in agreement with histological studies [37-39].
A
Figure 1: Macular image segmentation using the custom-built software 
(OCTRIMA). (A) The image of a healthy macula scanned by STRATUS OCT. 
(B) The same OCT scan processed with OCTRIMA.
Ch: choroid; GCL+IPL: Ganglion Cell Layer and Inner Plexiform Layer 
complex; INL: Inner Nuclear Layer; ONL+IS: Combined Outer Nuclear Layer 
and Inner Segment of Photoreceptors; OS: Outer Segment of Photoreceptors; 
OPL: Outer Plexiform Layer; RNFL: Retinal Nerve Fiber Layer; RPE: Retinal 
Pigment Epithelial Layer; V: Vitreous. 
Note that OCTRIMA measures the thickness of the total retina between the 
inner limiting membrane and the inner boundary of the photoreceptor outer 
segment/RPE junction. The thickness of the combined ONL+IS structure is 
measured between the outer boundary of OPL and the inner boundary of the 
photoreceptor outer segment/RPE junction.
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Thickness and reflectance-based measurements were extracted for 
each of the 6 radial OCT scans using features measured locally for each 
intraretinal layer for study and control eyes. The macular region was 
divided into four separate regions (Figure 2) [40]. The central disc is 
the foveolar area with a diameter of 0.35 mm. The remaining rings are 
the fovea, parafoveal and perifoveal areas with a diameter of 1.85, 2.85 
and 5.85 mm, respectively [40]. Contrary to the thickness mapping per 
macular sectors defined by the Early Treatment Diabetic Retinopathy 
Study (ETDRS) and adopted by OCT software developers; the 
custom-built thickness mapping in OCTRIMA allows the collection 
of information in the foveal, parafoveal and the prerifoveal regions 
[17,31]. Reflectance measurements were used in the calculation of 
layer index values based on previous work from Pons et al. [41]. 
Particularly, the layer index values were calculated by taking a ratio 
of measured reflectivity per A-scan against the saturation reflectivity 
of each image (B-scan) and multiplying this ratio by the measured 
thickness per A-scan. The mean thickness and layer index measures 
in each intraretinal layer were calculated using the following analyses: 
1) by averaging the local thickness and layer index measures across 
all macular regions (i.e. the entire macula) in all study groups, and 2) 
by averaging the local thickness and layer index measures across each 
separated macular region (i.e. foveal, parafoveal and perifoveal) in all 
study groups. Because the RNFL, GCL+IPL and INL are not present 
in the foveal center, the analysis of these layers excluded the foveolar 
region where these inner retinal layers are difficult to detect due to the 
low OCT signal.
To improve the precision of structural and optical feature 
calculations, a blood vessel shadowgram technique based on the 
reflectivity distribution was employed to detect the lateral coordinates 
of the blood vessel shadows on OCT images [42]. Reflectance-based 
measures were expressed in absolute units (a.u) and converted to 
decibels (dB); where 0.1 log unit of attenuation=1 dB. The mean values 
were calculated per intraretinal layer across the six radial OCT scans. 
Scans were cropped to remove peripheral areas where segmentation 
was less reliable due to low OCT signal. Factors extrinsic to the retina, 
such as media opacity, poor focusing, and scanning pitfalls, were 
removed by taking the ratio of the average reflectivity signal within 
the retina and each intraretinal layers and dividing it by the average 
reflectivity signal from a reference layer. Accordingly, the analyses 
performed using parameters based on optical properties considered 
mean reflectivity values that were calculated using reflectivity with 
normalization to the RPE reflectance (NRPE). The image processing 
and diagnostic parameter calculations were programmed in Matlab 
7.0 (The Mathworks, Natick, Massachusetts). ANOVA followed by 
Newman-Keuls post-hoc analyses were used to test for differences 
between groups. Because of the large number of comparisons a 
modified p value of <0.001 was considered statistically significant.
Results
A total of 155 eligible eyes from 99 participants were analyzed, 
which included a total of 74 healthy eyes (34 ± 12 years, 52 female, 22 
male), 38 eyes with type 1 diabetes mellitus (DM) with no retinopathy 
(35 ± 10 years, 20 female, 18 male) and 43 eyes with mild diabetic 
retinopathy (MDR, 43 ± 17 years, 21 female, 22 male). The demographic 
and clinical characteristics of the study population are summarized in 
Table 1.
In the analysis where local thickness and reflectance-based measures 
were averaged across all macular regions, the mean thicknesses of the 
GCL+IPL complex, OPL and OS were statistically significant smaller 
(8%, 13% and 11%, respectively, p<0.001) in the MDR eyes compared 
to controls (Table 2, Figure 3). Moreover, the mean thicknesses of 
the OPL, OS and RPE were statistically significant smaller (10%, 20% 
and 7%, respectively, p<0.001) in the MDR eyes compared to the DM 
eyes. Significant smaller (13-24%) layer index values were observed 
in all layers in the MDR eyes compared with healthy-control eyes 
(except in the ONL+IS and RPE, Table 3). Particularly, layer index was 
significantly smaller in the RNFL, GCL+IPL complex, INL, OPL and 
OS (13%, 21%, 14%, 24% and 13%, respectively, p<0.001) in MDR eyes 
compared to controls in the analysis across all macular regions (Table 
3). Moreover, when comparing MDR with DM eyes, the layer index 
values showed significant differences for all intraretinal layers (except 
in the RNFL, ONL+IS and RPE). Specifically, the layer index values 
were significantly smaller in the GCL+IPL, INL, OPL and OS (16%, 
15%, 23% and 17%, respectively). Figures 4A and 5A show the thickness 
and layer index changes in the intraretinal layers for measures averaged 
across all macular regions. The numerical data are shown in Tables 2 
and 3.
In the analysis where local thickness and reflectance-based measures 
were averaged in the separated macular regions outside the foveola (i.e. 
foveal, parafoveal and perifoveal) in all study groups, the mean thickness 
of the parafoveal GCL+IPL complex and foveal OPL were significantly 
smaller in the MDR eyes compared to healthy controls (by 8% and 
B
d c b a b c d
Figure 2: Custom-built method showing macular sectors. A) Fundus 
image of a healthy eye showing the STRATUS OCT’s radial lines protocol. B) 
Regions shown are: foveola (a) with a diameter of 0.35 mm, foveal region (b) 
with a diameter of 1.85 mm, parafoveal region (c) with a diameter of 2.85 mm 
and perifoveal (d) region with a diameter of 5.85 mm.
MDR vs. Healthy MDR vs. DM
RPE
OS
ONL+IS
OPL
RNFL
GCL+IPL
INL
Figure 3: Thickness changes in each macular region and intraretinal 
layer for MDR vs. healthy and MDR vs. DM eyes. Comparisons were 
performed by ANOVA followed by Newman-Keuls post hoc analysis. The red 
and yellow color denotes p<0.001 and 0.001<p<0.05, respectively. Arrows 
pointing down denote the decreasing trend observed.
DM: Diabetic patients with no diabetic retinopathy; MDR: Diabetic patients 
with mild diabetic retinopathy 
For the description of layer abbreviations see the text or Figure 1.
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36%, respectively, p<0.001, Table 2). However, the mean thickness 
of the GCL+IPL complex was significantly bigger in the foveal region 
(26%, p<0.001) when comparing MDR eyes with healthy control eyes. 
Moreover, the mean thickness of the OS was only significantly smaller 
in the perifoveal (13%, p<0.001) and parafoveal (13%, p<0.001) regions 
when comparing MDR eyes with healthy controls. The mean thickness 
of the RNFL was significantly smaller in the parafoveal (7%, p<0.001) 
and in the perifoveal (8%, p<0.001) regions in MDR eyes compared to 
healthy controls. The mean thickness of the INL was only significantly 
bigger (19%, p<0.001) in the foveal region when comparing MDR eyes 
with controls. Furthermore, when comparing MDR with DM eyes, the 
mean thickness of the GCL+IPL complex (parafoveal region) and OPL 
(foveal region) was significantly smaller (by 7% and 27%, respectively, 
p<0.001). In addition, the mean thickness of the OS was significantly 
smaller in the foveal (17%, p<0.001), parafoveal (24%, p<0.001) and 
perifoveal (23%, p<0.001) regions when comparing MDR with DM 
eyes. The mean thickness of the RNFL was significantly smaller in the 
foveal (30%, p<0.001), parafoveal (8%, p<0.001) and perifoveal (6%, 
Characteristic Controls DM MDR
Number of Participants 41 29 29
Number of Eyes 74 38 43
Age (years, mean ± SD) 34 ± 12 35 ± 10 43 ± 17
Female, N (% total eyes) 52 (70%) 20 (53%) 21 (49%)
Race (% Caucasian) 100 100 91
Hemoglobin A1c level (%) - 7.20 ± 0.90 8.51 ± 1.76
DM duration (years, mean ± SD) - 13 ± 5 22 ± 10
IOP (mmHg, mean ± SD) 14. 5 ± 1.23 15.74 ± 1.77 15.09 ± 1.56
BCVA 1.0 ± 0.00 1.0 ± 0.00 0.97 ± 0.06
Total macular thickness (μm ± SD) 324.36 ± 10.27 316.72 ± 21.56 297.40 ± 21.79
SD: Standard Deviation; BCVA: Best Corrected Visual Acuity
Table 1: Descriptive statistics of the study participants.
† 0.001<p<0.05 and ‡ p<0.001 (ANOVA followed by Newman-Keuls post hoc analysis). For comparisons between MDR and healthy eyes (see MDR column); and between 
MDR and DM eyes (see DM column). Changes in percentage are indicated at the upper left of each measure
SD: Standard Deviation; MDR: Mild Diabetic Retinopathy; DM: Diabetes Mellitus
Table 2: Distribution statistics of thickness (mean ± SD) by study group.
Thickness (μm) Healthy DM MDR
Across All Macular Regions
RNFL   42.02 ± 2.11 41.19 ± 2.19 41.38 ± 2.93
GCL+IPL 78.30 ± 4.09 7 5.4 1 ± 5.2 3 † (-8 %)71 .80 ± 8.22 ‡
INL 35.02 ± 1.60 35.74 ± 2.13 35.05 ± 2.76
OPL 41.30 ± 2.49 (-10%)39.88 ± 5.04 ‡ (-13%)36.07 ± 3.45 ‡
ONL+IS 86.41 ± 5.21 85.55 ± 7.32 88.39 ± 8.21
OS 16.27 ± 3.06 (-20%)17.97 ± 2.64 ‡ (-11%)14.40 ± 2.20 ‡
RPE 12.71 ± 1.32 (-7%)13.78 ± 1.28 ‡ 12.76 ± 1.09
Foveal Region
RNFL 8.85 ± 2.37 (-30%)11.83 ± 2.45 ‡ 8.30 ± 2.44
GCL+IPL 55.80 ± 3.87 67.58 ± 15.20 (+26%)70.26 ± 11.02 ‡
INL 20.93 ± 1.82 25.89 ± 4.30 (+19%)25.00 ± 4.85 ‡
OPL 61.24 ± 6.83 (-27%)53.08 ± 18.22 ‡ (-36%)38.97 ± 12.09 ‡
ONL+IS 99.26 ± 6.79 97.42 ± 8.92 100.35 ± 12.27
OS 18.05 ± 4.03 (-17%)19.53 ± 3.14 ‡ 16.22 ± 2.96 †
RPE 12.84 ± 1.72 14.06 ± 1.59 † 13.10 ± 1.32
Parafoveal Region
RNFL 33.72 ± 1.85 (-8%)34.16 ± 1.48 ‡ (-7%)31.33 ± 5.23 ‡
GCL+IPL 94.71 ± 5.73 (-7%)92.93 ± 6.75 ‡ (-8%)86.73 ± 11.2 ‡
INL 39.60 ± 2.17 40.49 ± 2.68 39.24 ± 3.32
OPL 37.17 ± 2.68 38.15 ± 2.54 37.07 ± 2.21
ONL+IS 84.89 ± 6.11 83.24 ± 8.16 † 86.85 ± 8.35
OS 14.80 ± 3.58 (-24%)16.97 ± 2.99 ‡ 12.84 ± 2.50 †
RPE 11.57 ± 1.59 13.08 ± 1.74 † 12.02 ± 1.64
Perifoveal Region
RNFL 41.87 ± 2.94 (-6%)41.39 ± 2.68 ‡ (-8%)38.7 ± 5.47 ‡
GCL+IPL 67.36 ± 4.52 64.39 ± 6.07 63.89 ± 8.40 †
INL 33.00 ± 1.67 33.38 ± 1.91 32.77 ± 3.12
OPL 31.54 ± 1.38 31.86 ± 1.49 31.49 ± 2.17
ONL+IS 75.27 ± 4.84 74.67 ± 7.01 † 78.01 ± 6.50 †
OS 14.59 ± 2.81 (-23%)16.45 ± 2.64 ‡ (-13%)12.72 ± 2.31 ‡
RPE 12.54 ± 1.39 13.33 ± 1.51 † 12.44 ± 1.34
Citation: DeBuc D, Tatrai E, Laurik L, Varga BE, Olvedy V, et al. (2013) Identifying Local Structural and Optical Derangement in the Neural Retina of 
Individuals with Type 1 Diabetes. J Clin Exp Ophthalmol 4: 289. doi:10.4172/2155-9570.1000289
Page 5 of 9
Volume 4 • Issue 4 • 1000289J Clin Exp OphthalmolISSN: 2155-9570 JCEO, an open access journal
Layer Index Healthy DM MDR
Across All Macular Regions
RNFL 12.38 ± 1.36  11.59 ± 1.19 † (-13%)10.81 ± 1.38 ‡
GCL+IPL 13.81 ± 2.10 (-16%)12.98 ± 1.79 ‡ (-21%)10.96 ± 1.87 ‡
INL 4.36 ± 0.84 (-15%)4.40 ± 0.78 ‡ (-14%)3.74 ± 0.69 ‡
OPL 6.28 ± 1.25 (-23%)6.20 ± 1.48 ‡ (-24%)4.75 ± 0.74 ‡
ONL+IS 7.59 ± 1.58 7.22 ± 1.22 † 6.52 ± 1.48 †
OS 6.09 ± 0.77 (-17%)6.42 ± 0.61 ‡ (-13%)5.32 ± 0.49 ‡
RPE 6.26 ± 0.52 6.61 ± 0.53 † 6.19 ± 0.43
Foveal Region
RNFL 7.27 ± 0.93 7.03 ± 1.07 † (-12%)6.43 ± 1.13 ‡
GCL+IPL 14.93 ± 2.50 (-24%)13.98 ± 2.93 ‡ (-29%)10.66 ± 2.01 ‡
INL 4.42 ± 0.95 (-17%)4.64 ± 1.02 ‡ 3.87 ± 0.71 †
OPL 8.95 ± 2.04 (-35%)8.72 ± 3.15 ‡ (-36%)5.71 ± 1.40 ‡
ONL+IS 8.55 ± 1.85 8.23 ± 1.48 † 7.28 ± 1.94 †
OS 6.37 ± 0.99 (-17%)6.62 ± 0.68 ‡ (-14%)5.51 ± 0.60 ‡
RPE 6.48 ± 0.63 6.85 ± 0.60 † 6.48 ± 0.52
Parafoveal Region
RNFL 9.84 ± 1.05 (-11%)9.62 ± 1.00 ‡ (-13%)8.57 ± 1.23 ‡
GCL+IPL 16.11 ± 2.53 (-17%)15.55 ± 2.12 ‡ (-19%)12.97 ± 2.33 ‡
INL 4.75 ± 0.96 (-16%)4.82 ± 0.87 ‡ (-15%)4.04 ± 0.75 ‡
OPL 5.96 ± 1.26 (-17%)6.15 ± 1.25 ‡ (-14%)5.11 ± 0.86 ‡
ONL+IS 7.75 ± 1.62 7.27 ± 1.19 † (-14%)6.66 ± 1.32 ‡
OS 6.02 ± 1.00 (-21%)6.52 ± 0.74 ‡ (-14%)5.18 ± 0.71 ‡
RPE 5.79 ± 0.64 6.32 ± 0.69 † 5.91 ± 0.68
Perifoveal Region
RNFL 14.02 ± 1.69 (-8%)13.27 ± 1.39 ‡ (-13%)12.16 ± 1.68 ‡
GCL+IPL 12.56 ± 1.96 11.66 ± 1.61 † (-17%)10.46 ± 2.01 ‡
INL 4.19 ± 0.80 (-13%)4.15 ± 0.72 ‡ (-14%)3.59 ± 0.74 ‡
OPL 4.87 ± 0.94 (-14%)4.79 ± 0.79 ‡ (-16%)4.11 ± 0.74 ‡
ONL+IS 6.79 ± 1.42 6.41 ± 1.12 5.92 ± 1.36 †
OS 5.88 ± 0.75 (-18%)6.28 ± 0.71 ‡ (-12%)5.16 ± 0.61 ‡
RPE 6.07 ± 0.55 6.34 ± 0.64 † 5.94 ± 0.54
†0.001<p<0.05 and ‡ p<0.001 (ANOVA followed by Newman-Keuls post hoc analysis). For comparisons between MDR and healthy eyes (see MDR column); and between 
MDR and DM eyes (see DM column). Changes in percentage are indicated at the upper left of each measure.
SD: Standard Deviation; MDR: Mild Diabetic Retinopathy; DM: Diabetes Mellitus
Table 3: Distribution statistics of the layer index (arbitrary units) by study group.
p<0.001) regions in MDR eyes compared to DM eyes (Table 2). The 
layer index values were smaller for all layers in MDR eyes compared 
with healthy and DM eyes. Statistically significant layer index changes 
are shown in Table 3. Figures 4B-4D and 5B-5D show the thickness and 
layer index changes in each macular region and intraretinal layers in 
the study groups with the numerical data represented in Tables 2 and 3.
Discussion
This study demonstrates that the outer photoreceptor segment is 
shorter in human subjects with type 1 diabetes, which could be revealed 
after improving the diagnostic power of OCT imaging by using a 
customized local image analysis as well as a combination of thickness 
and optical properties measures to characterize the diseased retina. 
In addition, these results showed that the thickness and reflectance of 
the OPL in MDR eyes was significantly smaller compared with similar 
measures in normal healthy eyes. Furthermore, the observed statistical 
trend of smaller layer index values indicates higher scattering in MDR 
eyes compared to controls, which might reflect macular diabetic 
damage due to increased disorganization in the cellular layers of the 
retina.
These results are consistent with findings of previous in vitro and 
in vivo experiments inducing apoptosis in animal models of diabetic 
eyes [6,43]. Previous studies have shown that retinal pericytes and 
endothelial cells are susceptible to hyperglycemia, but that also 
neuroglial elements of the retina are also involved in the retinal damage 
caused by diabetes [12,13]. According to Barber and colleagues, 
apoptosis is likely to occur in ganglion cells and other retinal neurons 
such as cells of the plexiform and nuclear layers [6]. Thus, the possibility 
that damage to the neuroglial retina causes or contributes to the 
capillary degeneration may be consistent with evidence that neuroglial 
degeneration precedes the degeneration of retinal capillaries in diabetic 
retinopathy [6]. In addition, some horizontal cells might be sensitive 
to small modification in the capillaries where post-synaptic processes 
of some OPL horizontal cells are found [44,45]. Accordingly, thinning 
of this layer might represent early indication of vascular degeneration 
that could be detected by investigating the changes in optical properties 
and thickness of the OPL.
The current study also showed that, compared with the standard 
thickness measurements provided by current commercial OCT devices, 
the combination of thickness and reflectance-based measurements 
using a local analysis approach yields more distinguishing information 
when investigating structural and optical properties of the retinal 
tissue in diabetic eyes. This particular result might add diagnostic 
power to the current capabilities offered by advanced imaging OCT 
technologies (e.g. SD-OCT, swept-source OCT, polarization sensitive 
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OCT and ultra-high resolution OCT). Therefore, the diagnostic power 
of OCT would be improved by adding diagnostic parameters based 
on local structural descriptors and reflectance change measures of the 
backscattered signal from layered retinal structures in diseased eyes.
The focus of experimental and human studies of the neural retina 
has primarily been the inner neurosensory retina where the retinal 
vasculature is distributed [6,20-30,46-54]. These studies have identified 
correlates of the functional deficits occurring early in the course of the 
disease. However, which type of retinal neurons undergoes apoptopic 
death is controversial.
Relatively little attention has been directed towards the outer 
neurosensory retina in the macular area [8,55,56]. For example, 
apoptosis of photoreceptors in streptozotocin-induced diabetic rats 
and abnormal color and contrast sensitivity in patients with DR suggest 
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that visual dysfunction in DR may be initiated from the loss of the 
photoreceptors [8,55,57-59].
The main benefit of employing a local approach for the data analysis 
is a more focused examination of the photoreceptors being abundantly 
present in the outer foveal region. In contrast to most studies for DR 
detection using OCT, our local approach does not take into account 
the area of the macular regions to calculate the mean values of OCT 
measurements. In addition, no interpolation is used in our method. 
Consequently, a more effective approach to accurately detect the 
location with most severe local neuronal losses would help to better 
discriminate eyes with early retinopathy from healthy controls and DM 
eyes as compared to the usual average and regional measures in ETDRS 
maps.
Our results show that looking for abnormalities in the GCL+IPL 
complex, OPL and OS across all macular regions could potentially detect 
DR earlier than clinical examination or standard imaging techniques 
allow. This study demonstrates that the quantifiable thinning of RNFL, 
GCL+IPL, OPL and OS occurs in diabetic eyes. Possibly, layer index 
values of the RNFL, GCL+IPL complex, OPL and OS may provide 
beneficial information as reference values for diagnosing early diabetic 
retinopathy in DM subjects. When comparing data per macular sector 
between MDR eyes with both control and DM eyes, thinning was 
predominantly observed for the OS in the perifoveal region while it 
was only observed for the OPL in the foveal region, whereas in the 
parafoveal regions the GCL+IPL complex was thinner. The GCL+IPL 
complex’s thickening observed in the foveal region might be associated 
to the fact that adjacent segments may undergo compensatory 
dilation when a capillary segment or retinal structure is non perfused 
(like in the perifoveal region where thinning was observed), leading 
to maintenance of overall tissue volume or even swelling. It might 
also be associated to FAZ damage and/or metabolic changes of the 
ganglion cells, preceding the apoptosis. However, all the above are pure 
speculations that require further experiments and longitudinal analyses 
with a bigger study population. Moreover, statistically significant 
thickness changes of the RNFL were only observed in the parafoveal 
and perifoveal regions. The statistical trend observed for the thinning 
and smaller layer index values of the RNFL and GCL+IPL complex in 
MDR eyes might reflect neurodegenerative changes due to diabetes. 
These findings also have possible implications for the early detection 
of macular damage in diabetes. Because the macular region is rich in 
retinal ganglion cells, it could be suggested that diabetic damage of this 
region might occur early in the disease process. In fact, animal models 
of DR show significant loss of macular ganglion cells [6,12,14,43].
The results of the current study are consistent with results from 
a similar study using the STRATUS OCT unit (128 A-scans) and 
age-matched groups, which also found significant thinning of the 
GCL+IPL in the perifoveal macular region [51]. Particularly, this 
study showed a mean thickness difference of 5.42 µm in the pericentral 
ETDRS region between MDR and healthy eyes for the GCL+IPL 
complex, and a thickness variation of the GCL+IPL in the range of 
2.26 µm to 8.56 µm [51]. Similarly, our results showed that a mean 
thickness difference of 7.98 µm and a thickness variation in the range 
of 5.73 µm to 11.2 µm was observed in the perifoveal (i.e., pericentral 
as in ETDRS regions) macular region between MDR and healthy eyes 
for the GCL+IPL complex. As a previous study showed, our bigger 
mean thickness difference in MDR participants might be justified by 
a thinner GCL+IPL complex in the perifoveal region due to the longer 
duration of diabetes in our study population [22]. An additional 
explanation for the observed differences could be the different mean 
age of study participants in both studies. Although in both studies the 
mean duration of diabetes in patients with MDR was 8 to 9 years longer 
than in patients without DR, differences in the GCL+IPL’s thickness 
variation may also be explained by the different data sampling used in 
both studies (128 A-scans vs. 512 A-scans in our study) and different 
mean age in patients with MDR. We also note that our smaller thickness 
measurement variability could be related to the fact that our results are 
not biased by interpolation and averaging of the thickness values within 
the macular areas. Akshikar et al. has also reported significant thinning 
of the outer retinal segment in the ETDRS regions when investigating 
macular thickness differences in age-matched subjects using Spectralis 
SD-OCT [60]. Their study considered the OPL, ONL, IS, OS and RPE 
layers as a unique combined structure forming the outer segment of 
the retina. However, significant secluded changes of any of these outer 
retinal layers may be obscured in such analysis by considering several 
layers into the outer retinal segment. In contrast, significant thinning 
and smaller layer index values were particularly observed for the OS in 
all macular regions when comparing MDR with DM eyes using a local 
analysis in our study. Contrary to a previous study reporting thinning 
of the photoreceptor layer thickness (IS/OS) at the foveal centre in DM 
age-matched subjects without retinopathy (mean age: 50.92 ± 4.75 
years and 49.87 ± 5.50 years, in diabetics and controls), we observed 
thickening of the OS in younger DM age-matched participants (35 ± 
10) compared to controls (34 ± 12) [61]. However, compared to few 
studies reporting changes in the outer retinal segment when comparing 
the macular thickness in diabetic participants with/without retinopathy 
and control participants without diabetes, our study suggests the neural 
damage in the outer retina may be predominantly located in the OS 
[60,61]. Conversely, because the duration of disease was 22 years in the 
MDR group vs. 13 years in the DM group, outer retinal changes might 
be associated with long-term inner retinal pathology. Therefore, the 
possibility of outer retinal changes as a secondary effect to inner retinal 
changes cannot be discarded when comparing MDR with DM eyes.
There are limitations to the present study some of which might be 
improved in subsequent investigations. First, improved validation of the 
current methodology demands a larger patient population for analysis. 
Second, although the TD-OCT technology provides lower image 
resolution compared to advanced OCT technologies, the six retinal 
layers were reliably assessed and were the standard when this study was 
initiated in 2007; better results might be expected with advanced OCT 
imaging technologies mentioned earlier and should be the standard for 
future studies [36]. In addition, a high level repeatability, close to 1 µm, of 
OS thickness measurement is possible using OCTRIMA on STRATUS-
OCT images where the axial range (depth range) is 2 mm, consequently 
the 1024 axial pixels have a spacing of 2 µm (i.e. axial pixel resolution 
is 2 mm/1024) in depth [36]. Measured differences in OS thickness 
between groups that exceed 1 µm (i.e. higher than the OS repeatability) 
are therefore likely to reflect actual structural change. Though our 
analysis is not affected by interpolation errors, higher scanning speeds 
could permit a higher sampling density of the scanned region, requiring 
a more accurate representation of the retinal structure. Although 
optical properties of the retinal tissue are not standardized measures 
for detecting significant intraretinal changes, in contrast to thickness 
measurements, reflectance-based measures are direct measures 
obtained from OCT images. Therefore, as reported by previous studies 
comparing results between TD-OCT and SD-OCT devices, we expect 
the trends reported here to be replicated by advanced OCT devices 
[29,30]. Third, the collection of longitudinal data using functional 
tests such as multifocal ERG, contrast sensitivity and microperimetry 
would be beneficial in the future to corroborate the present proposition 
[62,63]. Fourth, only the DM group was age-matched to controls in 
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our study. It has been reported that the rod photoreceptor population 
in the human perimacular region is subject to approximately 30% loss 
over life and that those that remain suffer from extensive convolutions 
and localized swellings of their outer segments abnormally increasing 
their disc content and outer segment length [64]. In addition, later 
studies also reported that mostly the rods are affected by aging with 
their number reducing with age, while cones are stable over time 
[65,66]. We note that the STRATUS-OCT macular scan’s length is 
6 mm, therefore OS measurements include mostly cones, which are 
supposed to be stable over time as reported by other authors in the field 
[65,66]. Therefore, provided the OS length in humans increases with 
age in the perimacular region and that STRATUS-OCT measurements 
of the OS include mostly cones, we do not expect the aging effect to 
be responsible of the OS thinning observed in the MDR group even 
when an average age difference of nine years was in place between the 
healthy controls and the MDR group in our study. However, this would 
need to be verified in subsequent studies. In addition, study parameters 
were measured cross-sectionally and not longitudinally. Therefore, 
future studies should investigate whether changes attributed to age 
could be due to other factors (e.g. sex and race) that may vary between 
subjects. Fifth, because patients enrolled in our study were 91-100% 
Caucasian, results cannot be generalized to other racial populations. 
Despite these basic limitations, the data presented here reveal that the 
outer photoreceptor segment might be vulnerable in diabetic patients, 
adding to the increasing evidence about alternating neurodegenerative 
damage in DR. More comprehensive studies including investigations 
on larger subject populations and longitudinal studies using advanced 
OCT technologies are needed to confirm not only the non presence of 
age-related changes in photoreceptor morphology but the actual path 
and sequence of outer retinal alterations in diabetic eyes.
In summary, OCT is capable of detecting selective layer thinning, 
which may represent a subclinical, early change in eyes without DR. 
In addition, our results suggest that the reflectance-based measures 
are distinguishable even between age-matched diabetic eyes without 
retinopathy and healthy eyes. Therefore, the optical properties extracted 
from OCT images add significant evidence to the morphological 
information directly provided by OCT. This finding might allow 
earlier detection and treatment, and it may allow new insights on the 
pathogenesis of neurodegenerative changes in the diabetic retina. We 
could also demonstrate that the photoreceptor segment in the outer 
retina might be vulnerable in type 1 diabetic individuals with and 
without early DR. However, further investigation is required to find 
whether or not outer retinal changes might be associated with long-
term inner retinal pathology. Our results might also suggest that an 
early indication of vascular alteration development could be detected 
by investigating the changes in optical properties and thickness of the 
OPL. The study outcomes might pave way for ascertaining evidence 
about the alternate pathogenic mechanisms in DR and whether 
visual loss is initiated by neural dysfunction in the inner and/or 
outer retina rather than by the development of vascular changes. As 
a result, future therapeutic interventions would focus on recovery of 
neural impairment besides treating vascular impairment and thereby 
improving the likelihoods of better visual outcomes.
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